Home / People / Bruno Fonteyn
Picture of Bruno Fonteyn

Bruno Fonteyn

Senior Associate
Lawyer

CMS DeBacker
Chaussée de La Hulpe 178
1170 Brussels
Belgium
Languages French, Dutch, English

Before joining CMS De Backer’s Public Law department in October 2008, Bruno worked for five years as legal counsel for the National Council of the Order of Physicians.

He specialises in Health law, including regulatory matters, hospitals, medical equipment, medical experiments, bio banks and other Life Science matters. Furthermore, he acts in the areas of constitutional and administrative law.

Bruno is a member of the Ethical Committee of a University Hospital, where he delivers legal opinions on medical experiments and ethical matters.

more less

Education

  • 2003 - Université Catholique de Louvain, UCL (Law Degree)
  • 2003 - University of Sherbrooke, Canada
  • 2008 - Bar admission (Brussels, Belgium)
more less

Memberships

  • Legal adviser to the National Council of the Order of Physicians (2003-2008)
  • Member of the Ethical Committee of Erasme Hospital - ULB since March 2008
more less

Publications

  •  « Personalized medicine: a major challenge for social security systems », (with P. Slegers), in SCRIP Regulatory Affairs, CUBITT Consulting, 18 June 2014
  • “Distribution & Marketing of Drugs, Jurisdictional comparisons”, (with P. Slegers), European Lawyer Reference, 2013 p. 29
  • « La plate-forme eHealth – Enjeux de santé publique et de sécurité sociale », (with C. Dubois), Journal des Tribunaux, 24 November 2012, n° 6498,  p. 769 à 776
  • «La directive 2011/24/UE relative à l’application des droits des patients en matière de soins de santé transfrontaliers : bien plus qu’une codification» (with P. Slegers), European Journal of Consumer Law, Larcier, n° 1/2012, p. 61-79
  • «Indemnisation des dommages résultant de soins de santé : le Fonds est mort, vive le Fonds !», (with C. Pouppez and P. Slegers), J.T., 14 mai 2011, n° 6437, p. 373 à 380
  • Comments about « Ziekenhuizen, mededingingsrecht en recht op kwaliteitsvolle zorg” (D. Fornaciari, S. Callens et E. Schokkaert), B. Fonteyn, J.T., 2010, p. 707
  • “L’utilisation de matériel corporel humain à des fins scientifiques: commentaires à propos de la loi du 19 décembre 2008”, co-author with P. Slegers, Journal des Tribunaux, 2009, p. 205
  • “Het Elektronisch Medisch Dossier: uit wettelijk en deontologisch standpunt bekeken”, co-author with Prof. Dr. Michel Deneyer en Prof. Dr. Etienne De Groot, De Praktijkjurist XV, Story, Conferentie van de Jonge Balie te Brugge, 2009, p. 1
  • “L’Ordre des médecins et la procédure disciplinaire”,  co-author with D. Holsters, Le droit disciplinaire des Ordres professionnels (under P. Corvilain supervision), Formation Permanente CUP, 2004, vol. 74
more less

Feed

Show only
01 May 2019
Con­sumer Products News­let­ter
Learn more about the latest de­vel­op­ments of the Con­sumer Products sec­tor.
20 April 2020
CMS Ex­pert Guide to can­nabis law and le­gis­la­tion
Are you look­ing for in­form­a­tion on can­nabis law and le­gis­la­tion? This CMS Ex­pert Guide provides you with everything you need to know.
31 July 2020
The cre­ation of loc­al hos­pit­al net­works sub­ject to mer­ger con­trol
The Bel­gian Com­pet­i­tion Au­thor­ity pub­lished on 22 Ju­ly 2020 its po­s­i­tion on the ap­plic­a­tion of mer­ger con­trol to loc­al hos­pit­al net­works. This doc­u­ment ad­dresses ques­tions from the hos­pit­al sec­tor con­cern­ing...
22/03/2019
Voors­chriften mo­eten elektron­isch zijn vanaf 1 janu­ari 2020
18 June 2019
The Bel­gian Com­pet­i­tion Au­thor­ity con­demns the Or­der of Phar­macists for...
On 28 May 2019, the Bel­gian Com­pet­i­tion Au­thor­ity ruled that the Or­der of Phar­macists had used its in­flu­ence to hinder the busi­ness activ­it­ies of the in­nov­at­ive phar­macy and paraphar­macy chain Medi­Care-Mar­ket. ...
30/11/2018
Novem­ber 2018 News­let­ter
26 March 2019
Bel­gi­um sub­mits draft bill on dis­trib­ut­ing medi­cin­al can­nabis
On 6 Feb­ru­ary 2019, a draft bill was sub­mit­ted to the House of Rep­res­ent­at­ives es­tab­lish­ing a gov­ern­ment agency for can­nabis that would have the ex­clus­ive right to dis­trib­ute medi­cin­al can­nabis. The draft...
November 2018
NGOS CAN ASK THE COM­MIS­SION TO RE­VIEW ITS DE­CISION ON GE­NET­IC­ALLY MOD­I­FIED...
BIO-SCI­ENCE LAW RE­VIEW - VOL 16 IS­SUE 6 BSLR : CASE COM­MENTS
26 March 2019
EU con­tin­ues fight against fals­i­fied medi­cines
Fol­low­ing the European Fals­i­fied Medi­cines Dir­ect­ive, new safety meas­ures entered in­to force in the EU on 9 Feb­ru­ary 2019 that guar­an­tee the iden­ti­fic­a­tion and au­then­ti­city of medi­cin­al products and must...
16/03/2018
March 2018 News­let­ter
05 December 2018
Im­port­ant leg­al changes in Bel­gi­um's health­care sec­tor
A new law was ad­op­ted on 30 Oc­to­ber 2018 con­tain­ing vari­ous pro­vi­sions on health. This law con­tains amend­ments to dif­fer­ent reg­u­la­tions in the health­care sec­tor. Some of the main changes are as fol­lows....
31/01/2018
Janu­ary 2018 News­let­ter